9 January 2017 - The future focussed Advisory Council will provide the Board with strategic advice on trends and issues impacting the Industry in the medium to long term (3 to 10 years).
This advice will inform the Board in setting the future strategic priorities for Medicines Australia and the innovative medicines and vaccines industry more broadly.